Consilient Health is pleased to announce it has taken over the UK marketing of Detrunorm® (Propiverine)
As of January 2022, Consilient Health is pleased to announce it has taken over the UK marketing of Detrunorm® (Propiverine) in conjunction with our partner Apogepha.
Available in the 15mg x 56 tablets, 30mg x 28 MR Capsules, and 45mg x 28 MR Capsules,
All 3 SKU’s are available through Alliance wholesale.
For product details please visit our products page
